- Quillivant and QuilliChew Shortage Disrupts ADHD Treatment
Pfizer, which produces both medications, sent a Drug Shortage Communication to healthcare professionals on November 8, 2017 The drug manufacturer indicated that, due to an undisclosed “manufacturing issue,” its supply of Quillivant XR, a liquid form of methylphenidate, would be short later that month The shortage of QuilliChew, a chewable version of the same medication, was predicted to
- URGENT: Important Prescribing Information Update Quillivant XR . . .
In order to alleviate the current drug shortage of Quillivant XR® (methylphenidate HCl) for extended- release oral suspension (300 mg, 600 mg, 750 mg and 900 mg), Pfizer is coordinating with the U S Food and Drug Administration (FDA) to help ensure availability of the drug Accordingly, Pfizer is releasing eleven lots (see Table 1(A)) –of Quillivant XR to address the current critical
- Quillivant XR DHCPL Final - U. S. Food and Drug Administration
In order to alleviate the current drug shortage of Quillivant XR® (methylphenidate HCl) for extended- release oral suspension (300 mg, 600 mg, 750 mg and 900 mg), Pfizer is coordinating with the
- Texas accuses Pfizer, Tris of providing compromised ADHD meds
Sales of Quillivant reached $193 million in 2017 In 2018, a shortage issue caused Quillivant to lose its small portion of market share, according to an SEC filing
- Drug Shortage Detail: Methylphenidate Extended Release Oral . . . - ASHP
Teva discontinued the 10 mg, 20 mg, and 30 mg extended-release (CD) capsules in late-2024 Trigen states the reason for the shortage is increased demand Tris Pharma has Quillichew ER chewable tablets and Quillivant XR liquid available Vertical states the reason for the shortage is increased demand
- November 8, 2017 Dear Health Care Professional,
As a result of a manufacturing issue, Quillivant XR® (methylphenidate HCl) oral suspension and QuilliChew ER® (methylphenidate HCl) chewable tablet will experience a supply shortage Quillivant XR will experience a supply shortage as soon as November 2017 QuilliChew ER will experience a supply shortage beginning December 2017 Pfizer is working diligently to resolve the issue, however the
- ADHD Medication Shortage Due to Manufacturing Delays
ADHD treatments and pills According to the FDA, Quillivant XR and ER are currently in shortage Quillivant XR (methylphenidate HCl ext-rel; Pfizer) oral suspension and Quillichew ER
- Maker of Pfizer med warned for continued testing issues
During an early 2017 inspection, regulators found that five lots of Quillivant XR, a Pfizer Inc drug for attention deficit hyperactivity disorder, had failed dissolution testing at the facility between March and November 2016
|